Prime members save up to 92% on ED treatment versus popular subscription service alternatives.” Meanwhile, Hims & Hers has seen its stock see-saw this year. Shares more than doubled once the ...

BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.

The announcement is Amazon’s most recent move into the pharmacy space Amazon Amazon continued its move into the pharmacy ...

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

Hims packages its ED products in discreet envelopes ... The generic versions of those drugs may differ slightly from the original patented drugs, although the active ingredients are the same.

The results come as those drugs, like Wegovy and Ozempic, explode in popularity, leading to shortages as well as greater competition. Executives on Monday said those supply constraints were "not ...

“Patients sometimes tell me that they ‘hear bad things’ about [ED treatments],” Dr. Gross told The Post. “These medications are among the most broadly prescribed drugs of the last ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has ...